Ashleigh Palmer, President and CEO at Provention Bio, Inc. (PRVB), bought 500 shares at $12.69 ($6K) on 2020-08-18, disclosed to the SEC on 2020-08-18.
Open-market purchase of $6k PRVB by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| PRVB | BUY | 2021-12-01 | $25K | — | Filing → |
| PRVB | BUY | 2020-08-17 | $36K | — | Filing → |
| PRVB | BUY | 2019-12-23 | $24K | — | Filing → |